-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Entrada Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
- Entrada Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 35.5M shares, a 7.07% increase year-over-year.
- Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 33.1M shares, a 5.62% increase from 2022.
- Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 31.3M shares, a 399% increase from 2021.
- Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 6.27M shares, a 467% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)